NM_001093.4:c.2144+65_2144+72delTTCCTTCC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001093.4(ACACB):c.2144+65_2144+72delTTCCTTCC variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.30 ( 5208 hom., cov: 0)
Exomes 𝑓: 0.11 ( 19630 hom. )
Failed GnomAD Quality Control
Consequence
ACACB
NM_001093.4 intron
NM_001093.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.21
Publications
0 publications found
Genes affected
ACACB (HGNC:85): (acetyl-CoA carboxylase beta) Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. [provided by RefSeq, Oct 2022]
ACACB Gene-Disease associations (from GenCC):
- isolated cleft palateInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 12-109188171-CTCCTTCCT-C is Benign according to our data. Variant chr12-109188171-CTCCTTCCT-C is described in ClinVar as Benign. ClinVar VariationId is 402333.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.356 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001093.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACACB | NM_001093.4 | MANE Select | c.2144+65_2144+72delTTCCTTCC | intron | N/A | NP_001084.3 | O00763-1 | ||
| ACACB | NM_001412734.1 | c.2144+65_2144+72delTTCCTTCC | intron | N/A | NP_001399663.1 | O00763-1 | |||
| ACACB | NM_001412735.1 | c.2144+65_2144+72delTTCCTTCC | intron | N/A | NP_001399664.1 | O00763-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACACB | ENST00000338432.12 | TSL:1 MANE Select | c.2144+10_2144+17delTCCTTCCT | intron | N/A | ENSP00000341044.7 | O00763-1 | ||
| ACACB | ENST00000377848.7 | TSL:1 | c.2144+10_2144+17delTCCTTCCT | intron | N/A | ENSP00000367079.3 | O00763-1 | ||
| ACACB | ENST00000377854.9 | TSL:5 | c.-1859+10_-1859+17delTCCTTCCT | intron | N/A | ENSP00000367085.6 | F8W8T8 |
Frequencies
GnomAD3 genomes AF: 0.296 AC: 31008AN: 104784Hom.: 5209 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
31008
AN:
104784
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0866 AC: 16188AN: 187034 AF XY: 0.0795 show subpopulations
GnomAD2 exomes
AF:
AC:
16188
AN:
187034
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.106 AC: 131609AN: 1244726Hom.: 19630 AF XY: 0.113 AC XY: 69439AN XY: 614048 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
131609
AN:
1244726
Hom.:
AF XY:
AC XY:
69439
AN XY:
614048
show subpopulations
African (AFR)
AF:
AC:
1994
AN:
27798
American (AMR)
AF:
AC:
3753
AN:
35682
Ashkenazi Jewish (ASJ)
AF:
AC:
3332
AN:
21684
East Asian (EAS)
AF:
AC:
7317
AN:
32842
South Asian (SAS)
AF:
AC:
12957
AN:
70864
European-Finnish (FIN)
AF:
AC:
13487
AN:
44604
Middle Eastern (MID)
AF:
AC:
768
AN:
4386
European-Non Finnish (NFE)
AF:
AC:
81208
AN:
956656
Other (OTH)
AF:
AC:
6793
AN:
50210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
3803
7606
11409
15212
19015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.296 AC: 31021AN: 104872Hom.: 5208 Cov.: 0 AF XY: 0.295 AC XY: 14651AN XY: 49622 show subpopulations
GnomAD4 genome
AF:
AC:
31021
AN:
104872
Hom.:
Cov.:
0
AF XY:
AC XY:
14651
AN XY:
49622
show subpopulations
African (AFR)
AF:
AC:
4733
AN:
27838
American (AMR)
AF:
AC:
2460
AN:
10050
Ashkenazi Jewish (ASJ)
AF:
AC:
748
AN:
2694
East Asian (EAS)
AF:
AC:
965
AN:
3236
South Asian (SAS)
AF:
AC:
754
AN:
2426
European-Finnish (FIN)
AF:
AC:
2640
AN:
6566
Middle Eastern (MID)
AF:
AC:
84
AN:
210
European-Non Finnish (NFE)
AF:
AC:
17990
AN:
49884
Other (OTH)
AF:
AC:
422
AN:
1328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
936
1872
2809
3745
4681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.